Literature DB >> 2506119

Serum levels of apolipoprotein A-I, A-II and HDL-cholesterol in second half of normal pregnancy and in pregnancy complicated by pre-eclampsia.

U Rosing1, G Samsioe, A Olund, B Johansson, A Kallner.   

Abstract

Serum concentrations of Apolipoprotein A-I and A-II, (Apo A-1 and Apo A-II) HDL-cholesterol (HDL-C), Total Cholesterol (TC), triglycerides (TG) and lipoprotein electrophoresis were assayed serially in the second half of normal pregnancy (21 women), in pre-eclampsia (26 women) and in both groups one and six weeks after delivery. In the normal group we found increased concentrations of Apo A-I and HDL-C, which remained unaltered during pregnancy. Apo A-II was unchanged. Correlation coefficients for Apo A-II vs HDL-C and Apo A-I vs Apo A-II decreased gradually towards delivery while it remained at an elevated and unaltered level for Apo A-I vs HDL-C. The Apo A-I/HDL-C ratio was unaltered during the whole study while the Apo A-I/A-II ratio was elevated during pregnancy and the Apo A-II/HDL-C ratio was reduced. These results may indicate a gradual change in the surface structure of the HDL particle or its subfractions. In pre-eclampsia Apo A-I and HDL-C concentrations were reduced, TG was increased and Apo A-II and TC were unchanged when compared with the normal pregnancy group. A more pronounced correlation coefficient was recorded for Apo A-I vs HDL-C than for Apo A-II vs HDL-C and Apo A-I vs Apo II. The results indicate that from an atherogenic point of view normal pregnancy seems more beneficial than pre-eclampsia.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2506119     DOI: 10.1055/s-2007-1009242

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  9 in total

Review 1.  Pathophysiology and maternal biologic markers of preeclampsia.

Authors:  Jacques Massé; Yves Giguère; Abdelaziz Kharfi; Joël Girouard; Jean-Claude Forest
Journal:  Endocrine       Date:  2002-10       Impact factor: 3.633

2.  Proteomic profile of uterine luminal fluid from early pregnant ewes.

Authors:  Jill M Koch; Jayanth Ramadoss; Ronald R Magness
Journal:  J Proteome Res       Date:  2010-08-06       Impact factor: 4.466

3.  Maternal hyperlipidemia and the risk of preeclampsia: a meta-analysis.

Authors:  Cassandra N Spracklen; Caitlin J Smith; Audrey F Saftlas; Jennifer G Robinson; Kelli K Ryckman
Journal:  Am J Epidemiol       Date:  2014-07-02       Impact factor: 4.897

4.  A controlled study of maternal serum concentrations of lipoproteins in pregnancy-induced hypertension.

Authors:  H Franz; D Wendler
Journal:  Arch Gynecol Obstet       Date:  1992       Impact factor: 2.344

5.  Hypertension in pregnancy: The endocrine and metabolic aspect.

Authors:  Navneet Magon; Sanjiv Chopra; G S Joneja
Journal:  Indian J Endocrinol Metab       Date:  2011-10

6.  Seminal Plasma Induces Overexpression of Genes Associated with Embryo Development and Implantation in Day-6 Porcine Blastocysts.

Authors:  Cristina A Martinez; Josep M Cambra; Maria A Gil; Inmaculada Parrilla; Manuel Alvarez-Rodriguez; Heriberto Rodriguez-Martinez; Cristina Cuello; Emilio A Martinez
Journal:  Int J Mol Sci       Date:  2020-05-22       Impact factor: 5.923

7.  apoA2 correlates to gestational age with decreased apolipoproteins A2, C1, C3 and E in gestational diabetes.

Authors:  Manjunath Ramanjaneya; Alexandra E Butler; Mohammed Bashir; Ilham Bettahi; Abu Saleh Md Moin; Lina Ahmed; Mohamed A Elrayess; Steven C Hunt; Stephen L Atkin; Abdul Badi Abou-Samra
Journal:  BMJ Open Diabetes Res Care       Date:  2021-03

8.  Genetic markers for preeclampsia in Peruvian women.

Authors:  José Pacheco-Romero; Oscar Acosta; Doris Huerta; Santiago Cabrera; Marlene Vargas; Pedro Mascaro; Moisés Huamán; José Sandoval; Rudy López; Julio Mateus; Enrique Gil; Enrique Guevara; Nitza Butrica; Diana Catari; David Bellido; Gina Custodio; Andrea Naranjo
Journal:  Colomb Med (Cali)       Date:  2021-02-26

9.  Comparison of lipid profiles in normal and hypertensive pregnant women.

Authors:  I Cüneyt Evrüke; S Cansun Demir; Ibrahim F Urünsak; F Tuncay Ozgünen; Oktay Kadayifçi
Journal:  Ann Saudi Med       Date:  2004 Sep-Oct       Impact factor: 1.526

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.